Increasing evidence suggests that natural metabolites can inhibit pancreatic acinar cell apoptosis by targeting the NF-κB signaling pathway, highlighting their therapeutic potential for AP. The gene discussed is NFKB1; the disease is alkaline phosphatase measurement.